Skip to main content
. 2012 Aug;19(8):1326–1328. doi: 10.1128/CVI.00060-12

Table 1.

Contribution of each biological test for congenital toxoplasmosis diagnosis

Biological test No. of infected children with positive biological test (n = 118)
Prenatal diagnosis (amniotic fluid) (PCR targeting the 529-bp repeat element and/or gene B1) 49
Neonatal IgM serology (<1 mo of life) (Toxo-ISAGA [bioMérieux]; IgM Enzygnost Toxoplasmosis [Dade Behring]) 54
Neonatal IgA serology (<1 mo of life) (Toxo-ISAGA [bioMérieux]; ToxoIgA [SFRI]) 56
Persistence of IgG within 12 mo (VIDIA Toxo IgGII [bioMérieux]; VIDAS Toxo IgG [bioMérieux]; IgG Enzygnost Toxoplasmosis [Dade Behring]) 18
Immunoblot mother-infant profile comparison (Toxoplasma WB IgG IgM [LD-Bio]) 93